As of 2024-12-12, the Relative Valuation of Quantum Genomics SA (ALQGC.PA) is (2.45) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.07 EUR, the upside of Quantum Genomics SA based on Relative Valuation is -3504.2%.
The range of the Relative Valuation is (1.96) - (2.96) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 27.0x | 18.2x |
| Forward P/E multiples | 14.6x - 22.0x | 18.2x |
| Fair Price | (1.96) - (2.96) | (2.45) |
| Upside | -2823.4% - -4211.2% | -3504.2% |
| Date | P/E |
| 2024-10-24 | -0.53 |
| 2024-10-23 | -0.54 |
| 2024-10-22 | -0.56 |
| 2024-10-21 | -0.54 |
| 2024-10-18 | -0.55 |
| 2024-10-17 | -0.53 |
| 2024-10-16 | -0.55 |
| 2024-10-15 | -0.57 |
| 2024-10-14 | -0.54 |
| 2024-10-11 | -0.58 |
| 2024-10-10 | -0.57 |
| 2024-10-09 | -0.57 |
| 2024-10-08 | -0.63 |
| 2024-10-07 | -0.62 |
| 2024-10-04 | -0.56 |
| 2024-10-03 | -0.58 |
| 2024-10-02 | -0.65 |
| 2024-10-01 | -0.68 |
| 2024-09-30 | -0.70 |
| 2024-09-27 | -0.58 |
| 2024-09-26 | -0.19 |
| 2024-09-25 | -0.20 |
| 2024-09-24 | -0.22 |
| 2024-09-23 | -0.22 |
| 2024-09-20 | -0.22 |
| 2024-09-19 | -0.16 |
| 2024-09-18 | -0.11 |
| 2024-09-17 | -0.11 |
| 2024-09-16 | -0.10 |
| 2024-09-13 | -0.12 |
| 2024-09-12 | -0.08 |
| 2024-09-11 | -0.08 |
| 2024-09-10 | -0.09 |
| 2024-09-09 | -0.10 |
| 2024-09-06 | -0.18 |
| 2024-09-05 | -0.06 |